STOCK TITAN

Nuburu WTS (BURUW) 424B Filings

BURUW OTC

Here are the 424B prospectus supplements from Nuburu Inc WTS (BURUW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow BURUW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BURUW filings page.

Rhea-AI Summary

Nuburu, Inc. is registering up to 230 million shares of common stock for resale by YA II PN, LTD., the selling stockholder from a recent financing. These shares are tied to a $25,000,000 debenture and four warrant series that together cover 230,000,000 warrant shares with exercise prices ranging from $0.01 to $0.47 per share. Nuburu will not receive proceeds from resales, but could receive cash if the warrants are exercised, which could total about $46,925,000 before fees if all are exercised in cash.

The company completed this financing after a going‑concern qualified audit opinion and continues to report large accumulated losses. A 19.99% NYSE American “Exchange Cap” and a 4.99% beneficial ownership limit restrict how many shares can be issued to the selling stockholder without shareholder approval. Nuburu also has a $100,000,000 standby equity purchase agreement that can direct all proceeds to repaying the debenture, and warns that extensive past and potential future share issuances may significantly dilute existing holders and pressure the stock price.

Rhea-AI Summary

Nuburu, Inc. is registering up to 130 million shares of common stock for resale by a single selling stockholder under a standby equity purchase agreement. These shares may be issued to YA II PN, LTD under a $100 million equity facility that Nuburu can draw on at its discretion, with purchase prices based on a discount to recent volume-weighted average trading prices.

Nuburu will not receive proceeds from the resale of these shares, though it may raise capital by selling new shares to the investor under the agreement. As of December 8, 2025, 437,987,341 shares of common stock were outstanding.

The company highlights significant risks: potential substantial dilution and share price pressure from multiple financing and resale transactions, a history of substantial losses and going‑concern uncertainty, dependence on closing several planned acquisitions, and the need for additional capital to execute its transformation strategy. Nuburu has received a NYSE American noncompliance notice and has previously restated financial statements and identified material weaknesses in internal controls.

Rhea-AI Summary

Nuburu, Inc. (BURUW) filed a Form 424B4 prospectus describing an offering of Pre-Funded Warrants and Common Warrants and disclosing material corporate and financing developments. The document sets placement agent fees at up to 7.5% on gross proceeds up to $10,000,000 and an additional 6.0% on amounts above $10,000,000. It warns investors of immediate dilution, potential cashless warrant exercises that amplify dilution, and that the company will likely need additional capital even if the offering is successful. The filing discloses numerous unsecured convertible notes issued in 2025 with conversion prices tied to discounted VWAPs, an Agile Note bearing 44% interest with weekly repayments through November 2025, and multiple financings and exchanges with Indigo Capital, Brick Lane, Bomore, Torcross and others. The company has received an NYSE American notice of noncompliance regarding delisting proceedings for its Public Warrants, recorded material weaknesses and restatements tied to debt accounting, and large potential share issuances from conversions/options/notes that could substantially dilute shareholders. The prospectus also highlights product advantages of its blue laser technology and strategic focus on defense licensing.